Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Smoother silicone breast implants can reduce inflammation and other immune system reactions

According to researchers at Johns Hopkins Medicine, the Massachusetts Institute of Technology (MIT) and Rice University in Houston, silicone breast implants with a smoother surface design have less risk of producing inflammation and other immune system reactions than those with more roughly textured coatings.

22 Jun 2021

New test bed launched to advance the regenerative medicine field

The RegeneratOR Test Bed has officially launched, bringing together resources to advance the regenerative medicine field nationally and create an economic development engine for the region and the state overall.

22 Jun 2021

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum (WMF) 2021 (poster #: 5574).

21 Jun 2021

University of Louisville receives NIH funding to support research into liver-related illness

The University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence has received $11.3 million in funding from the National Institutes of Health to support its research into liver-related illness for an additional five years.

21 Jun 2021

Novel vaccine based on mRNA technology protects against malaria in animal models

Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology that protects against malaria in animal models, publishing their findings in npj Vaccines.

18 Jun 2021

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

A new study, released as a preprint on the bioRxiv* server, reveals the high neutralizing efficacy of hyperimmune horse serum against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could prove, if validated, to be a more affordable yet potent therapeutic in reducing the morbidity and mortality caused by this virus.

18 Jun 2021

Device makers have funneled billions to orthopedic surgeons who use their products

Dr. Kingsley R. Chin was little more than a decade out of Harvard Medical School when sales of his spine surgical implants took off.

17 Jun 2021

New transparent material can capture respiratory droplets effectively from air

Although plexiglass barriers are seemingly everywhere these days -- between grocery store lanes, around restaurant tables and towering above office cubicles -- they are an imperfect solution to blocking virus transmission.

17 Jun 2021

Researchers find several persistent industrial chemicals in fetal organs

Researchers at Karolinska Institutet in Sweden found industrial chemicals in the organs of fetuses conceived decades after many countries had banned the substances.

16 Jun 2021

New computational topology strategy to identify existing medicines for treating COVID-19

Researchers from the ESI International Chair of the CEU Cardenal Herrera University (CEU UCH) and ESI Group have just published in scientific journal Pharmaceutics a new computational topology strategy to identify existing medicines that could be applied to treat COVID-19 without waiting for the research and clinical trial phases required to develop a new medicine.

16 Jun 2021

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

A new study, released as a preprint on the bioRxiv* server, describes the late-stage clinical trial efficacy of a new vaccine candidate based on a deoxyribonucleic acid (DNA) plasmid platform expressing the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Among different constructs of the vaccine plasmid, the RBD was found to produce the most potent and broad immune response.

16 Jun 2021

New AI model could help predict which viruses are likely to spread from animals to humans

A new model that applies artificial intelligence to carbohydrates improves the understanding of the infection process and could help predict which viruses are likely to spread from animals to humans.

15 Jun 2021

ACT Accelerator partnership welcomes commitment of 870 million vaccine doses, highlights funding gaps

At the close of this year’s G7 Leaders’ summit, the Prime Minister of the United Kingdom of Great Britain and Northern Ireland announced a donation of an additional 870 million vaccine doses from attendees, with the majority to be delivered through COVAX, the vaccines pillar of the Access to COVID 19 Tools Accelerator, within the next year.

15 Jun 2021

Global leaders pledge to share COVID-19 vaccine doses internationally at the G7 summit

In a landmark agreement at the G7 summit, held in Cornwall, the United Kingdom of Great Britain and Northern Ireland, global leaders have pledged to share COVID-19 vaccine doses internationally, in support of global equitable access and to help end the acute phase of the pandemic.

15 Jun 2021

FDA approves Stratagraft for thermal burn treatment in adult patients

Today, the U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns).

15 Jun 2021

Study finds ‘widespread’ use of toxic chemicals in a range of cosmetics

Cosmetics from the United States have been found to contain high levels of polyuoroalkyl substances (PFAS), associated with a range of harmful conditions.

15 Jun 2021

Stents inspired by kirigami could deliver drugs to tubular organs

Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used to deliver drugs to the gastrointestinal tract, respiratory tract, or other tubular organs in the body.

14 Jun 2021

UCSF launches new initiative to propel the development of living therapeutics

UC San Francisco is launching a new initiative to propel the development of living therapeutics - a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease - and bring them quickly to patients.

14 Jun 2021

Simpleware ScanIP Medical Receives FDA 510(k) Clearance for 3D Medical Printing

Synopsys’ Simpleware ScanIP Medical is now available for 3D medical printing after receiving FDA 510(k) clearance in this area.

From Synopsys Simpleware™ Software 14 Jun 2021

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Healthcare professionals and public health authorities have a central role in discussing vaccination against COVID-19 with their patients.

13 Jun 2021

Manufacturing News and Research

Further Reading

Smoother silicone breast implants can reduce inflammation and other immune system reactions

New test bed launched to advance the regenerative medicine field

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

University of Louisville receives NIH funding to support research into liver-related illness

Novel vaccine based on mRNA technology protects against malaria in animal models

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

Device makers have funneled billions to orthopedic surgeons who use their products

New transparent material can capture respiratory droplets effectively from air

Researchers find several persistent industrial chemicals in fetal organs

New computational topology strategy to identify existing medicines for treating COVID-19

COVID-e-Vax DNA vaccine candidate elicits robust immune responses in preclinical trials

New AI model could help predict which viruses are likely to spread from animals to humans

ACT Accelerator partnership welcomes commitment of 870 million vaccine doses, highlights funding gaps

Global leaders pledge to share COVID-19 vaccine doses internationally at the G7 summit

FDA approves Stratagraft for thermal burn treatment in adult patients

Study finds ‘widespread’ use of toxic chemicals in a range of cosmetics

Stents inspired by kirigami could deliver drugs to tubular organs

UCSF launches new initiative to propel the development of living therapeutics

Simpleware ScanIP Medical Receives FDA 510(k) Clearance for 3D Medical Printing

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News